Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
CoreWeave, Inc. - Class A Common Stock
(NQ:
CRWV
)
125.06
-2.00 (-1.57%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 21, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about CoreWeave, Inc. - Class A Common Stock
CoreWeave Reaffirms Strategic Rationale of its Proposed Acquisition and Financial Benefits to Core Scientific Stockholders
October 16, 2025
From
CoreWeave Inc.
Via
Business Wire
CoreWeave Appoints Jon Jones as First Chief Revenue Officer to Lead Next Phase of Rapid Growth
October 16, 2025
From
CoreWeave
Via
Business Wire
CoreWeave Unveils AI Object Storage, Redefining How AI Workloads Access and Scale Data
October 16, 2025
From
CoreWeave, Inc.
Via
Business Wire
CoreWeave Announces Partnership with Foundation Model Company Poolside to Deliver AI Cloud Services
October 15, 2025
From
CoreWeave, Inc.
Via
Business Wire
CoreWeave Launches First Publicly Available Serverless Reinforcement Learning Capability to Build Reliable AI Agents
October 08, 2025
From
CoreWeave, Inc.
Via
Business Wire
CoreWeave to Acquire Monolith, Expanding AI Cloud Platform into Industrial Innovation
October 06, 2025
From
CoreWeave, Inc.
Via
Business Wire
CoreWeave Expands Agreement with OpenAI by up to $6.5B
September 25, 2025
From
CoreWeave, Inc.
Via
Business Wire
CoreWeave to Participate in the Jefferies Virtual AI Summit
September 24, 2025
From
CoreWeave Inc.
Via
Business Wire
CoreWeave Announces £1.5 Billion Commitment to Power UK AI Innovation and Growth Through Sustainable Computing
September 16, 2025
From
CoreWeave, Inc.
Via
Business Wire
CoreWeave Launches Ventures Group to Invest in Future of AI
September 09, 2025
From
CoreWeave
Via
Business Wire
CoreWeave to Acquire OpenPipe, Leader in Reinforcement Learning
September 03, 2025
From
CoreWeave, Inc.
Via
Business Wire
CoreWeave to Participate in the Goldman Sachs Communacopia + Technology Conference
August 27, 2025
From
CoreWeave Inc.
Via
Business Wire
CoreWeave to Participate in the Deutsche Bank Technology Conference
August 14, 2025
From
CoreWeave Inc.
Via
Business Wire
CoreWeave Reports Strong Second Quarter 2025 Results
August 12, 2025
From
CoreWeave, Inc.
Via
Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: STAAR Surgical Company (Nasdaq – STAA), Y-mAbs Therapeutics, Inc. (Nasdaq – YMAB), Couchbase, Inc. (Nasdaq – BASE), Core Scientific, Inc. (Nasdaq - CORZ)
August 05, 2025
From
Brodsky & Smith LLC
Via
GlobeNewswire
CoreWeave Closes $2.6 Billion Secured Debt Financing Facility, Strengthening Market Position as AI Cloud Leader
July 31, 2025
From
CoreWeave, Inc.
Via
Business Wire
CoreWeave Announces Closing of $1,750 million of Senior Notes Offering
July 28, 2025
From
CoreWeave, Inc.
Via
Business Wire
CoreWeave Announces Date of Second Quarter 2025 Financial Results
July 23, 2025
From
CoreWeave, Inc.
Via
Business Wire
CoreWeave Announces Upsize and Pricing of $1,750 million of Senior Notes
July 22, 2025
From
CoreWeave, Inc.
Via
Business Wire
CoreWeave Announces Intention to Offer $1,500 million of Senior Notes
July 21, 2025
From
CoreWeave, Inc.
Via
Business Wire
Weights & Biases Announces Availability of W&B Weave in the New AWS Marketplace AI Agents and Tools Category
July 16, 2025
From
CoreWeave
Via
Business Wire
CoreWeave Announces Multi-Billion Dollar Commitment to AI Infrastructure in Pennsylvania
July 15, 2025
From
CoreWeave
Via
Business Wire
CoreWeave to Acquire Core Scientific
July 07, 2025
From
CoreWeave
Via
Business Wire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.